Karyopharm Announces Publication of XPOVIO® (Selinexor) Phase 3 BOSTON Study Results in The Lancet

Press/Media

Period12 Nov 2020

Media coverage

1

Media coverage

  • TitleKaryopharm Announces Publication of XPOVIO® (Selinexor) Phase 3 BOSTON Study Results in The Lancet
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date12/11/20
    PersonsSundar Jagannath
View all 1
View less